Prostate cancer registry for men in the Ohio region
Part of Cancer, Kidney & urinary clinical trials.
This trial is a registry that collects information from men with prostate cancer to help doctors learn more about the disease and improve care. It is open to people recently diagnosed (since 2023) who live in Ohio, Kentucky, or Indiana.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with prostate cancer (confirmed by a biopsy or medical test).
- Your diagnosis happened on or after January 1, 2023.
- You are at least 18 years old.
- You live in Ohio, Kentucky, or Indiana.
- You do not have any other cancer besides a common skin cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a worldwide registry that collects health information from men with advanced prostate cancer. It may help researchers better understand disease patterns and outcomes, which can guide future treatments.
This registry collects information from people with prostate cancer to better understand how genetics and treatments affect survival and outcomes. Your data may help researchers improve future treatment choices.
This study builds a database of people with localized or locally advanced prostate cancer to better understand patient-reported outcomes (your experiences and quality-of-life). It may help improve future care by collecting consistent feedback from patients.
This study asks men with prostate cancer about their experience preparing for and joining clinical trials. It may help improve how future trials are explained and supported for patients.
This study collects information from men with prostate cancer to better understand how different treatments work in real life. It follows patients when they start a new treatment and can help improve future care.
This is a registry study that follows men with low-risk prostate cancer who choose active surveillance instead of immediate treatment. It helps doctors understand how safe and effective active surveillance is, including confirming results with repeat biopsies.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.